4/A: USANA Executive Daniel A. Macuga Reports Sale of Shares
SEC Filing (Form 4/A)
Daniel A. Macuga, Chief Communications Officer of USANA Health Sciences, sold 3,791 shares of common stock at an average price of $47.1424 on May 2, 2024.
Summary
- On May 2, 2024, Daniel A. Macuga, the Chief Communications Officer of USANA Health Sciences, sold 3,791 shares of the company's common stock.
- The sale was executed at a weighted average price of $47.1424 per share.
- The price range for the multiple transactions was between $47.0709 and $47.31.
- This Form 4/A is an amendment to the original Form 4 filed on May 2, 2024, to reflect that the reporting individual is no longer subject to Section 16 reporting.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This filing is a routine disclosure of insider trading activity. It provides transparency to the market regarding transactions by company executives.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 05/02/2024 | Date of original Form 4 filing and the stock sale transaction. |
| 05/02/2024 | Date of the transaction. |
| 05/06/2024 | Date of the amended filing (Form 4/A). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.